23.03.2018 • NewsCristalElaine BurridgeTronox

EU Objects to Tronox-Cristal Merger

EU Objects to Tronox-Cristal Merger
EU Objects to Tronox-Cristal Merger

The European Commission has issued a statement of objections to Tronox regarding its proposed $2.4 billion acquisition of Cristal’s titanium dioxide (TiO2) business. Tronox is required to respond to the objections by early April.

“The statement of objections further details and clarifies the commission’s position, and receipt of it establishes a defined framework to move forward,” said Tronox CEO Jeffry Quinn. We continue in constructive dialogue, and I am confident we can determine an appropriate and proportionate resolution to any valid concerns of the Commission.”

The mining and inorganic chemicals company added that the statement of objections does not prejudge the outcome of the Commission’s investigation nor the need to offer any particular remedy.

Tronox is already suing the US Federal Trade Commission (FTC) on the deal, alleging the agency is using delaying tactics to block the acquisition, which was originally announced in February 2017.

On Mar. 1, the companies extended their purchase agreement from May 21 to Jun. 30, with automatic three-month extensions perpetuating until Mar. 21 2019, to allow more time to secure the outstanding regulatory approvals.

The deal has already been cleared by the authorities in Australia, China, New Zealand, Turkey, South Korea and Colombia.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.